RNAM – (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

RNAM

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

2/27

03:29 pm

rnam

Form 4 Avidity Biosciences, For: Feb 27 Filed by: McCarthy Teresa

Neutral Report

Form 4 Avidity Biosciences, For: Feb 27 Filed by: McCarthy Teresa

Report

2/27

03:27 pm

rnam

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Thompson Tamar

Neutral Report

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Thompson Tamar

Report

2/27

03:25 pm

rnam

Form 4 Avidity Biosciences, For: Feb 27 Filed by: MacLean Michael F

Neutral Report

Form 4 Avidity Biosciences, For: Feb 27 Filed by: MacLean Michael F

Report

2/27

03:23 pm

rnam

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Skerjanec Simona

Neutral Report

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Skerjanec Simona

Report

2/27

03:20 pm

rnam

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Hughes Steven George

Neutral Report

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Hughes Steven George

Report

2/27

03:20 pm

rnam

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Boyce Sarah

Neutral Report

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Boyce Sarah

Report

2/27

03:18 pm

rnam

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Moriarty John B

Neutral Report

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Moriarty John B

Report

2/27

03:17 pm

rnam

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Flanagan W. Michael

Neutral Report

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Flanagan W. Michael

Report

2/27

03:15 pm

rnam

Form 4 Avidity Biosciences, For: Feb 27 Filed by: WILSON TROY EDWARD

Neutral Report

Form 4 Avidity Biosciences, For: Feb 27 Filed by: WILSON TROY EDWARD

Report

2/27

03:14 pm

rnam

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Gallagher Kathleen P.

Neutral Report

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Gallagher Kathleen P.

Report

2/27

03:11 pm

rnam

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Henig Noreen

Neutral Report

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Henig Noreen

Report

2/27

03:06 pm

rnam

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Kim Jean Jinsun

Neutral Report

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Kim Jean Jinsun

Report

2/27

02:56 pm

rnam

Form 4 Avidity Biosciences, For: Feb 27 Filed by: LEVIN ARTHUR A

Neutral Report

Form 4 Avidity Biosciences, For: Feb 27 Filed by: LEVIN ARTHUR A

Report

2/27

02:51 pm

rnam

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Kaye Edward M. MD

Neutral Report

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Kaye Edward M. MD

Report

2/27

02:50 pm

rnam

Form 4 Avidity Biosciences, For: Feb 27 Filed by: BOESS CARSTEN

Neutral Report

Form 4 Avidity Biosciences, For: Feb 27 Filed by: BOESS CARSTEN

Report

2/27

02:48 pm

rnam

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Mosbrooker Eric

Neutral Report

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Mosbrooker Eric

Report

2/27

02:48 pm

rnam

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Calderaro Charles III

Neutral Report

Form 4 Avidity Biosciences, For: Feb 27 Filed by: Calderaro Charles III

Report

2/27

10:06 am

rnam

Form 25-NSE Avidity Biosciences, Filed by: Nasdaq Stock Market LLC

Neutral Report

Form 25-NSE Avidity Biosciences, Filed by: Nasdaq Stock Market LLC

Report

2/27

09:51 am

rnam

Form POSASR Avidity Biosciences,

Neutral Report

Form POSASR Avidity Biosciences,

Report

2/27

09:48 am

rnam

Form POSASR Avidity Biosciences,

Neutral Report

Form POSASR Avidity Biosciences,

Report

2/27

09:46 am

rnam

Form POSASR Avidity Biosciences,

Neutral Report

Form POSASR Avidity Biosciences,

Report

2/27

09:39 am

rnam